Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Peter Kwasny"'
Autor:
Peter Kwasny, Maik Pechoel, Günter Niegisch, Roswitha Siener, Susanne Krege, Sabine Kliesch, Anna Fingerhut, Kai-Uwe Köhrmann, Jan Lehmann, Klaus-Peter Dieckmann, Peter Albers, Michael Hartmann, Hans-Ulrich Schmelz, Axel Heidenreich, Volker Loy, Rolf Fimmers, Andreas Hiester, Christian Wittekind
Publikováno v:
European Journal of Cancer. 155:64-72
Background One cycle of adjuvant chemotherapy with bleomycin, etoposide and cisplatin (BEP) has shown superiority in recurrence-free survival over retroperitoneal lymph node dissection (RPLND) in patients with clinical stage (CS) I non-seminomatous g
Autor:
Peter Albers, Michael Hartmann, Jan Lehmann, Andreas Hiester, Volker Loy, Anna Fingerhut, Sabine Kliesch, Maik Pechoel, Klaus-Peter Dieckmann, Rolf Fimmers, Peter Kwasny, Susanne Krege, Kai Uwe Koehrmann, Hans U. Schmelz, Christian Wittekind, Roswitha Siener, Axel Heidenreich, Guenter Niegisch
Publikováno v:
Journal of Clinical Oncology. 38:5512-5512
5512 Background: One cycle of adjuvant BEP has shown superiority in recurrence free survival over RPLND in patients (pts) with clinical stage (CS) I nonseminomatous germ cell tumor of the testis (NSGCT) (JCO 2008). We report recurrences and late toxi
Autor:
Susanne Krege, V. Loy, Hans U. Schmelz, L. Weißbach, Sabine Kliesch, Klaus-Peter Dieckmann, Christian Wittekind, Maik Pechoel, M. Hartmann, Roswitha Siener, Kai Uwe Köhrmann, Axel Heidenreich, P. Albers, Rolf Fimmers, Peter Kwasny, Jan Lehmann
Publikováno v:
Der Urologe. 48:523-528
Hintergrund Da 30% der Nichtseminome im klinischen Stadium I unter einer Surveillancestrategie progredient werden, konnen als adjuvante Therapien die nerverhaltende retroperitoneale Lymphadenektomie (RLA) oder 2 Zyklen Cisplatin/Etoposid/Bleomycin (P
Autor:
Rolf Fimmers, Lothar Weiβbach, Christian Wittekind, Michael Hartmann, Hans-Uwe Schmelz, Sabine Kliesch, Susanne Krege, Axel Heidenreich, Kai-Uwe Köhrmann, Maik Pechoel, Peter Kwasny, Volker Loy, Peter Albers, Klaus-Peter Dieckmann, Roswitha Siener, Jan Lehmann
Publikováno v:
Journal of Clinical Oncology. 26:2966-2972
Purpose Retroperitoneal lymph node dissection (RPLND) and adjuvant chemotherapy are two adjuvant treatment options for patients with clinical stage I nonseminomatous germ cell tumors of the testis (NSGCT). Aim of this trial was to prove the advantage
Autor:
Roswitha Siener, Susanne Krege, Michael Hartmann, L. Weißbach, Hans U. Schmelz, Sabine Kliesch, Kai Uwe Köhrmann, Axel Heidenreich, P. Albers, Rolf Fimmers, Peter Kwasny, Maik Pechoel, K.P. Dieckmann, Christian Wittekind, Jan Lehmann, V. Loy
Publikováno v:
European Urology Supplements. 7:84
Autor:
Michael Hartmann, Jan Lehmann, Maik Pechoel, Klaus-Peter Dieckmann, Peter Albers, Peter Kwasny, Roswitha Siener, Susanne Krege, Axel Heidenreich, Hans U. Schmelz, Rolf Fimmers
Publikováno v:
Journal of Clinical Oncology. 24:4512-4512
4512 Background: The incidence of relapse was analyzed in patients with clinical stage I (CS I) NSGCT after either retroperitoneal lymph node dissection (RPLND) or one course of adjuvant cisplatin, etoposide, and bleomycin (PEB) chemotherapy. Methods